Table 1.
Receptor | Ratio ADRB2 |
---|---|
TAS2R10 | 3.96 ± .893 |
TAS2R14 | 3.51 ± .397 |
TAS2R31 | 3.41 ± .498 |
TAS2R5 | 1.76 ± .190 |
TAS2R4 | 1.45 ± .271 |
TAS2R19 | 1.37 ± .249 |
TAS2R3 | 0.83 ± .079 |
TAS2R20 | 0.71 ± .202 |
TAS2R45 | 0.70 ± .118 |
TAS2R50 | 0.48 ± .033 |
TAS2R30 | 0.31 ± .060 |
TAS2R9 | 0.31 ± .034 |
TAS2R13 | 0.26 ± .037 |
TAS2R42 | 0.26 ± .009 |
TAS2R46 | 0.25 ± .041 |
TAS2R1 | 0.17 ± .027 |
TAS2R8 | 0.15 ± .007 |
TAS2R39 | ND |
TAS2R43 | ND |
TAS2R7 | ND |
TAS2R40 | ND |
TAS2R16 | ND |
TAS2R38 | ND |
TAS2R41 | ND |
TAS2R60 | ND |
TAS1R1 | ND |
TAS1R2 | ND |
ADRB2 | 1.0 (reference) |
ADORA1 | 2.43 ± .446 |
LTB4R | 0.29 ± .056 |
Results are normalized to expression of the ADRB2. ADORA1 and LTB4R represent high- and low-expressing GPCRs as positive controls, respectively. ND, not detected. Results are from 4–6 experiments.